These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 21166955

  • 21. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
    Adya R, Tan BK, Punn A, Chen J, Randeva HS.
    Cardiovasc Res; 2008 May 01; 78(2):356-65. PubMed ID: 18093986
    [Abstract] [Full Text] [Related]

  • 22. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
    Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M.
    Anticancer Res; 2009 Jan 01; 29(1):119-23. PubMed ID: 19331140
    [Abstract] [Full Text] [Related]

  • 23. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Carcinogenesis; 2012 May 01; 33(5):1022-30. PubMed ID: 22436611
    [Abstract] [Full Text] [Related]

  • 24. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.
    J Pharmacol Exp Ther; 2009 Jun 01; 329(3):1063-70. PubMed ID: 19258520
    [Abstract] [Full Text] [Related]

  • 25. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
    Mohammad G, AlSharif HM, Siddiquei MM, Ahmad A, Alam K, Abu El-Asrar AM.
    Ann Clin Lab Sci; 2018 Mar 01; 48(2):137-145. PubMed ID: 29678838
    [Abstract] [Full Text] [Related]

  • 26. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
    Kim KS, Yao L, Lee YC, Chung E, Kim KM, Kwak YJ, Kim SJ, Cui Z, Lee JH.
    Immunopharmacol Immunotoxicol; 2010 Dec 01; 32(4):600-6. PubMed ID: 20131957
    [Abstract] [Full Text] [Related]

  • 27. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.
    Ren X, Dai M, Lin LP, Li PK, Ding J.
    Br J Pharmacol; 2009 Apr 01; 156(8):1228-38. PubMed ID: 19302593
    [Abstract] [Full Text] [Related]

  • 28. EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.
    Geoerger B, Gaspar N, Opolon P, Morizet J, Devanz P, Lecluse Y, Valent A, Lacroix L, Grill J, Vassal G.
    Int J Cancer; 2008 Jul 01; 123(1):209-16. PubMed ID: 18386816
    [Abstract] [Full Text] [Related]

  • 29. Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells.
    Lu DY, Leung YM, Cheung CW, Chen YR, Wong KL.
    Biochem Pharmacol; 2010 Oct 15; 80(8):1201-9. PubMed ID: 20615395
    [Abstract] [Full Text] [Related]

  • 30. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
    Wang N, Guan P, Zhang JP, Li YQ, Chang YZ, Shi ZH, Wang FY, Chu L.
    J Cell Biochem; 2011 Jul 15; 112(7):1920-9. PubMed ID: 21433064
    [Abstract] [Full Text] [Related]

  • 31. Thrombin up-regulates vascular endothelial growth factor in experimental gliomas.
    Xu Y, Gu Y, Keep RF, Heth J, Muraszko KM, Xi G, Hua Y.
    Neurol Res; 2009 Sep 15; 31(7):759-65. PubMed ID: 19108760
    [Abstract] [Full Text] [Related]

  • 32. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B, Chang CM, Yuan M, McKenna WG, Shu HK.
    Cancer Res; 2003 Nov 01; 63(21):7443-50. PubMed ID: 14612544
    [Abstract] [Full Text] [Related]

  • 33. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
    Ou DL, Shen YC, Liang JD, Liou JY, Yu SL, Fan HH, Wang DS, Lu YS, Hsu C, Cheng AL.
    Clin Cancer Res; 2009 Sep 15; 15(18):5820-8. PubMed ID: 19737956
    [Abstract] [Full Text] [Related]

  • 34. Afadin Facilitates Vascular Endothelial Growth Factor-Induced Network Formation and Migration of Vascular Endothelial Cells by Inactivating Rho-Associated Kinase Through ArhGAP29.
    Tagashira T, Fukuda T, Miyata M, Nakamura K, Fujita H, Takai Y, Hirata KI, Rikitake Y.
    Arterioscler Thromb Vasc Biol; 2018 May 15; 38(5):1159-1169. PubMed ID: 29599137
    [Abstract] [Full Text] [Related]

  • 35. Antiangiogenic therapy in malignant glioma: promise and challenge.
    Sathornsumetee S, Rich JN.
    Curr Pharm Des; 2007 May 15; 13(35):3545-58. PubMed ID: 18220791
    [Abstract] [Full Text] [Related]

  • 36. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
    Zhu F, Zhang Z, Wu G, Li Z, Zhang R, Ren J, Nong L.
    Med Oncol; 2011 Jun 15; 28(2):565-71. PubMed ID: 20300976
    [Abstract] [Full Text] [Related]

  • 37. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y, Peng A, He S, Shao X, Nie C, Chen L.
    J Chemother; 2013 Oct 15; 25(5):298-308. PubMed ID: 24070138
    [Abstract] [Full Text] [Related]

  • 38. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.
    Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew D, Fujise K, Liu M.
    Cancer Res; 2009 Jan 15; 69(2):518-25. PubMed ID: 19147565
    [Abstract] [Full Text] [Related]

  • 39. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, Johnston P.
    Lab Invest; 1997 Apr 15; 76(4):565-77. PubMed ID: 9111517
    [Abstract] [Full Text] [Related]

  • 40. Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf/MEK/ERK pathway.
    Du W, Zhou JR, Wang DL, Gong K, Zhang QJ.
    World J Surg Oncol; 2012 Apr 21; 10():60. PubMed ID: 22520038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.